A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
Clinical trial NCT00964873 · COMPLETED
Trial details
- NCT number
- NCT00964873
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.